# SUMATRIPTAN SUCCINATE
> **ANDA207101** · Abbreviated New Drug Application (Generic) · Sponsor: BAXTER HLTHCARE CORP · Approved 2023-01-19
## Drug
- **FDA Application Number:** ANDA207101
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUMATRIPTAN SUCCINATE
- **Generic name:** SUMATRIPTAN
- **Active ingredients:** SUMATRIPTAN SUCCINATE
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** BAXTER HLTHCARE CORP
- **Manufacturer:** Baxter Healthcare Corporation
- **First approval:** 2023-01-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207101)
---
*AI Analytics · CC0 1.0*